US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist

24.690
+0.470+1.94%

Close Nov 22 16:00 ET

24.690
0.0000.00%

Post 20:01 ET

3.55BMarket Cap-8945P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Denali Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 5.000M	--
--	2024/Q4	-- / 11.615M	--
--	2024/Q3	0.000 / 8.357M	--
--	2024/Q2	0.000 / 10.773M	--
--	2024/Q1	0.000 / 13.022M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 5.000M--

--2024/Q4-- / 11.615M--

--2024/Q30.000 / 8.357M--

--2024/Q20.000 / 10.773M--

--2024/Q10.000 / 13.022M--

Unlock Free Earnings Estimates

Open Account

Denali Therapeutics Earnings Reports

Denali Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 05:22

Denali Therapeutics | 8-K: Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 7 05:21

Denali Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 1 18:57

Denali Therapeutics | 8-K: Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 1 18:51

Analyst Rating

Updated: Nov 22, 2024

Strong Buy

Buy
85.71%
Hold
14.29%
Sell
0.00%

Price Target

No Data

Heat List

Overall